LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -25.0% | 33,907 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -47.8% | 33,907 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -70.5% | 33,907 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -49.7% | 33,907 | 0.0% | 0.00% | – |
| Q3 2021 | $155,000 | +40.9% | 33,907 | +36.7% | 0.00% | – |
| Q2 2021 | $110,000 | -93.5% | 24,807 | -89.4% | 0.00% | – |
| Q1 2021 | $1,700,000 | +3.7% | 233,539 | +8.7% | 0.00% | – |
| Q4 2020 | $1,639,000 | +14.5% | 214,758 | +36.2% | 0.00% | – |
| Q3 2020 | $1,432,000 | +7.1% | 157,665 | -0.3% | 0.00% | – |
| Q2 2020 | $1,337,000 | +112.6% | 158,085 | +24.2% | 0.00% | – |
| Q1 2020 | $629,000 | -31.5% | 127,240 | -0.2% | 0.00% | – |
| Q4 2019 | $918,000 | -28.8% | 127,448 | +6.9% | 0.00% | – |
| Q3 2019 | $1,289,000 | -17.3% | 119,273 | -0.5% | 0.00% | – |
| Q2 2019 | $1,559,000 | +130.6% | 119,925 | +75.2% | 0.00% | – |
| Q1 2019 | $676,000 | +8.2% | 68,447 | +13.9% | 0.00% | – |
| Q4 2018 | $625,000 | – | 60,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,466,783 | $69,906,000 | 1.33% |
| Board of Trustees of The Leland Stanford Junior University | 949,443 | $10,264,000 | 1.11% |
| Lion Point Capital, LP | 500,000 | $5,405,000 | 0.60% |
| Sio Capital Management, LLC | 122,536 | $1,325,000 | 0.43% |
| Redmile Group, LLC | 749,026 | $8,097,000 | 0.27% |
| SAMLYN CAPITAL, LLC | 639,977 | $6,918,000 | 0.17% |
| Stanley-Laman Group, Ltd. | 19,530 | $211,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,378,475 | $14,901,000 | 0.04% |
| FRANKLIN RESOURCES INC | 700,000 | $7,567,000 | 0.00% |
| Jefferies Group LLC | 10,618 | $115,000 | 0.00% |